Skip to content
Tryp Therapeutics episode artwork

May 26, 2021 20 min

Tryp Therapeutics

from OTCQB Podcast Hosted by OTC Markets Group

Tryp Therapeutics (OTCQB: TRYPF) is a pharmaceutical company focused on identifying and developing clinical-stage compounds for the treatment of rare and other diseases with high unmet medical needs through regulatory pathways. CEO Gregory McKee joins us to discuss the current progress the company has had with scientific collaborations and clinical activities. View Podcast Transcript for Tryp Therapeutics

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Tryp Therapeutics

0:00 20:07

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 20 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on May 26, 2021.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.